LENZ Therapeutics (LENZ) Accumulated Depreciation & Amortization (2022 - 2025)
LENZ Therapeutics (LENZ) has disclosed Accumulated Depreciation & Amortization for 4 consecutive years, with $287000.0 as the latest value for Q4 2025.
- Quarterly Accumulated Depreciation & Amortization rose 394.83% to $287000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $287000.0 through Dec 2025, up 394.83% year-over-year, with the annual reading at $287000.0 for FY2025, 394.83% up from the prior year.
- Accumulated Depreciation & Amortization for Q4 2025 was $287000.0 at LENZ Therapeutics, up from $58000.0 in the prior quarter.
- The five-year high for Accumulated Depreciation & Amortization was $3.9 million in Q1 2023, with the low at $58000.0 in Q4 2024.
- Average Accumulated Depreciation & Amortization over 4 years is $1.9 million, with a median of $1.9 million recorded in 2022.
- The sharpest move saw Accumulated Depreciation & Amortization crashed 66.81% in 2023, then skyrocketed 394.83% in 2025.
- Over 4 years, Accumulated Depreciation & Amortization stood at $3.2 million in 2022, then tumbled by 73.87% to $838000.0 in 2023, then crashed by 93.08% to $58000.0 in 2024, then surged by 394.83% to $287000.0 in 2025.
- According to Business Quant data, Accumulated Depreciation & Amortization over the past three periods came in at $287000.0, $58000.0, and $838000.0 for Q4 2025, Q4 2024, and Q3 2023 respectively.